Skip to content

Jill Ge



Jill Ge
Jill Ge



Jill covers the full spectrum of IP litigation and transactions in China. Jill has extensive experience in contentious patent, trade secret and trade mark matters involving multinationals and in resolving cross-border disputes. She has been involved with a broad spectrum of key and important dispute matters including crown-jewel big pharma patent litigation as well as bet-the-farm IP arbitration.

Jill is extremely versatile. Drawing on her litigation experience, Jill also routinely advises on IP and data-heavy transactions and counsels technology and life science clients in relation to their development of IP strategies, as well as related regulatory and competition law issues. Jill has written extensively on IP developments in China, and one of her articles was quoted in an English Court of Appeal judgment (Conversant v Huawei). Jill has a technical background in physics and materials engineering. She studied law and was trained in the U.S. and qualified in the U.S. and China (non-practicing).

Related articles

A group of colleagues in a modern conference room

Publications: 10 January 2023

The key to unlocking a successful trade secrets strategy

Having the right procedures in place can avert breaches of sensitive information—and be crucial in case of emergencies.

Read more

Publications: 23 November 2022

A&O chips in with global tech savvy

Read more

Blog Post: 03 August 2022

China promulgates measures on security assessment for cross border transfer of data

Read more

Publications: 22 July 2022

China promulgates measures on security assessment for cross border transfer of data

Read more



15F, Phase II, Shanghai IFC, 8 Century Avenue, Pudong

View office →



Admitted to New York Bar, 2012

Qualified in China (non-practicing), 2020


J.D., cum laude, University of Minnesota Law School

M.S., Materials Science and Engineering, University of California, Irvine

B.S., Physics, Fudan University 

Published Work

  • Co-author, “Commercially essential patents recognised as essential facility in China”, A&O alert, May 2021
  • Co-author, “China: Patent Law Amendment brings sea change to pharmaceutical patent regime”, A&O alert, November 2020
  • Author, “How a Chinese court would have decided the Unwired Planet appeal”, IAM Blog, November 2018
  • Author, “China: Does bifurcation mean patent validity has to be decided first?”, Comparative Patent Remedies, May 2018
  • Co-author, “The Patent Litigation Law Review, China Chapter – Edition 1”, The Law Reviews, January 2018
  • Author, “Damages trends in China: what the shifting landscape means for rights holders”, World Trademark Review Magazine, October 2017
  • Author, “China: Beijing IP Court publishes initial results of case precedent pilot project”, INTA Bulletin, September 2017
  • Co-author, “Iwncomm v Sony: first SEP-based injunction granted in China”, A&O alert, April 2017
  • Author, “The Beijing IP Court’s 50 million RMB judgment in WatchData v Hengbao”, Comparative Patent Remedies, January 2017
  • Co-author, “SEP-based injunction, down but not out”, Kluwer Patent Blog, April 2016